Web Analytics Made Easy - StatCounter
Megapixl
Search results

Illustration: B-Lymphocyte Antigen Cd20 Epitope Peptide Fragment, Bound To Rituximab (Fab Fragment). Indications For Rituximab Include Leukemia

ID 188464569 © Molekuul | Megapixl.com

B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia, lymphoma and rheumatoid arthritis. 3D rendering based on protein data bank entry 2osl. Stick representation combined with semi-transparent surfaces. Dark background

CATEGORIES

Not to be used in commercial
designs and/or advertisements.
Click here for terms and conditions.
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia

Royalty-Free

extended licenses

I-EL W-EL P-EL U-EL
Your image is downloading.

Sharing is not just caring, it's also about giving credit - add this image to your page and give credit to the talented photographer who captured it.:

© Molekuul | Megapixl.com
HTML code

KEYWORDS

pdb2osl cd20 cd 20 cluster differentiation blymphocyte lymphocyte bcell antigen ms4a1 surface lymphoma leukemia immunohistochemistry histology antibody rituximab fab epitope autoimmune cancer rheumatoid arthritis purpura thrombocytopenic pemphigus vulgaris monoclonal structure peptide protein amino acid molecule polypeptide polymer atoms science scientific disease health molecular model 3d rendering illustration dark background black transparent artistic stylized

More images on Dreamstime

B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
Life Brand Vitamin B Complex with Vitamin C

Similar Images

B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
Dendritic cell presenting an antigen to T-lymphocytes
Humoral immunity. Lymphocyte, antibody and antigen
Adaptive immune system from Antigen presentation to activation o
CAR-T cell therapy
Inside the blood vessel, white blood cells inside
Activation of the immune response: antigen presenting cell activates T-lymphocytes (smaller c
Lymphocyte, closeup view of T-cell or B-cell
Leukocytes attack the virus in the blood. Microbes under the microscope. Disease, infection, inflammation
Humoral immunity. antibody-mediated immunity. Viruse, Lymphocyte, antibody and antigen. Vector diagram for educational, biological
B cell lymphocyte

More images by the same author

Vitamins (all except vitamin B12), chemical struct
Linoleic acid (LA)
Lidocaine
Taq Polymerase molecule
The 22 standard amino acids - chemical structures
Cortisone
Thyroxine molecule, chemical structure. Thyroid gland hormone th
Amino acids. 2D chemical structures of the 20 comm
Saturated fatty acids (set): caprylic, acid, capri
Thyroxine hormone molecule, chemical structure.
Human prion protein (hPrP), chemical structure. Associated with
IgG1 monoclonal antibody (immunoglobulin), 3D rendering. Many biotech drugs are antibodies. Atoms are shown as color-coded spheres
View more